Link to this page
Medical Subject Headings
Last uploaded:
August 28, 2024
Jump to:
Preferred Name | N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide | |
Synonyms |
Sch503034 Sch 503034 boceprevir victrelis Sch-503034 |
|
ID |
http://purl.bioontology.org/ontology/MESH/C512204 |
|
altLabel |
Sch503034 Sch 503034 boceprevir victrelis Sch-503034
|
|
cui |
C1738934 C3154650 C1741239
|
|
Has mapping qualifier | ||
HM |
D011392/Q000031
|
|
Inverse of RB |
89BT58KELH
|
|
LT |
TRD
|
|
Mapped to | ||
MDA |
20060802
|
|
MeSH Frequency |
606
|
|
MMR |
20160831
|
|
notation |
C512204
|
|
prefLabel |
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
|
|
SC |
1
|
|
Scope Statement |
Sch-503034 is the (1R,2S,5S)-isomer; an HCV protease inhibitor; structure in first source
|
|
SRC |
Antiviral Res 2006 Jun;70(2):28-38
|
|
TERMUI |
T684962 T000906391 T684960 T720487 T684961 T679088
|
|
TH |
NLM (2008) NLM (2012) USAN (19XX) INN (19XX) NLM (2006) FDA SRS (2015)
|
|
tui |
T116 T123 T121
|
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping